Publication:
Corrigendum to "Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells" [Biochem. Pharmacol. 176 (2020) 113902].

dc.contributor.authorRodríguez-Hernández, María A
dc.contributor.authorde la Cruz-Ojeda, Patricia
dc.contributor.authorGallego, Paloma
dc.contributor.authorNavarro-Villarán, Elena
dc.contributor.authorStaňková, Pavla
dc.contributor.authorDel Campo, José A
dc.contributor.authorKučera, Otto
dc.contributor.authorElkalaf, Moustafa
dc.contributor.authorMaseko, Tumisang E
dc.contributor.authorČervinková, Zuzana
dc.contributor.authorMuntané, Jordi
dc.date.accessioned2023-05-03T14:46:52Z
dc.date.available2023-05-03T14:46:52Z
dc.date.issued2022-11-18
dc.identifier.doi10.1016/j.bcp.2022.115351
dc.identifier.essn1873-2968
dc.identifier.pmid36410064
dc.identifier.urihttp://hdl.handle.net/10668/22031
dc.journal.titleBiochemical pharmacology
dc.journal.titleabbreviationBiochem Pharmacol
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.page.number115351
dc.pubmedtypePublished Erratum
dc.titleCorrigendum to "Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells" [Biochem. Pharmacol. 176 (2020) 113902].
dc.typeresearch article
dc.volume.number206
dspace.entity.typePublication

Files